Literature DB >> 9264366

The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women.

G Parham1, J L Phillips, M L Hicks, N Andrews, W B Jones, H M Shingleton, H R Menck.   

Abstract

BACKGROUND: Epithelial ovarian carcinoma is the fifth most common cause of cancer death among African-American women. Although the incidence rate of ovarian carcinoma for whites is higher than that for African Americans, the relative survival rate for African Americans is poorer.
METHODS: Data were cases submitted to the National Cancer Data Base for invasive epithelial tumors of the ovary diagnosed between 1985-1988 and 1990-1993. African-American women with epithelial ovarian carcinoma were compared with non-Hispanic white women with the same disease. The groups of white women with which African-American women were compared were classified as "White-same facility" and "White-other facility." "White-same facility" were white patients from hospitals that contributed a substantial proportion of African-American patients. "White-other facility" were white patients from hospitals that contributed few or no African-American patients. No patient had a history of prior cancer.
RESULTS: African-American women with advanced invasive epithelial ovarian carcinoma were less often treated with combined surgery and chemotherapy and more often treated with chemotherapy only. African-American women were twice as likely as white women not to receive appropriate treatment. African-American women had poorer survival rates than white women from the same or different hospitals, regardless of income. Among staged cases, African-American women were more often diagnosed with Stage IV disease than either group of white women.
CONCLUSIONS: The current study findings show that African-American women with advanced epithelial ovarian carcinoma received less aggressive treatment than white women and had a poorer prognosis.

Entities:  

Mesh:

Year:  1997        PMID: 9264366

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

1.  Racial differences in ovarian cancer risk.

Authors:  R B Ness; J A Grisso; J Klapper; R Vergona
Journal:  J Natl Med Assoc       Date:  2000-04       Impact factor: 1.798

2.  Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.

Authors:  Robert E Bristow; Jenny Chang; Argyrios Ziogas; Hoda Anton-Culver; Veronica M Vieira
Journal:  Gynecol Oncol       Date:  2014-03-25       Impact factor: 5.482

3.  Spatial analysis of advanced-stage ovarian cancer mortality in California.

Authors:  Robert E Bristow; Jenny Chang; Argyrios Ziogas; Daniel L Gillen; Lu Bai; Veronica M Vieira
Journal:  Am J Obstet Gynecol       Date:  2015-01-31       Impact factor: 8.661

Review 4.  Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.

Authors:  Yvonne Collins; Kevin Holcomb; Eloise Chapman-Davis; Dineo Khabele; John H Farley
Journal:  Gynecol Oncol       Date:  2014-01-07       Impact factor: 5.482

5.  Demographic, presentation, and treatment factors and racial disparities in ovarian cancer hospitalization outcomes.

Authors:  Tomi F Akinyemiju; Gurudatta Naik; Kemi Ogunsina; Daniel T Dibaba; Neomi Vin-Raviv
Journal:  Cancer Causes Control       Date:  2018-02-10       Impact factor: 2.506

6.  Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.

Authors:  Sherri L Stewart; Rhea Harewood; Melissa Matz; Sun Hee Rim; Susan A Sabatino; Kevin C Ward; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

7.  Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.

Authors:  Robert E Bristow; Matthew A Powell; Noor Al-Hammadi; Ling Chen; J Philip Miller; Phillip Y Roland; David G Mutch; William A Cliby
Journal:  J Natl Cancer Inst       Date:  2013-03-28       Impact factor: 13.506

8.  Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer.

Authors:  Mishka Terplan; Sarah Temkin; Ana Tergas; Ernst Lengyel
Journal:  Gynecol Oncol       Date:  2008-09-26       Impact factor: 5.482

9.  Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials.

Authors:  John H Farley; Chunqiao Tian; G Scott Rose; Carol L Brown; Michael Birrer; G Larry Maxwell
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

10.  The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago.

Authors:  Charlotte E Joslin; Katherine C Brewer; Faith G Davis; Kent Hoskins; Caryn E Peterson; Heather A Pauls
Journal:  Gynecol Oncol       Date:  2014-08-28       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.